latanoprost timolol maleate (Xalacom)

Advice

Following an abbreviated submission

latanoprost, timolol (Xalacom®) is accepted for use within NHS Scotland for reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

This abbreviated submission relates to a licence extension to cover use of this medicine in patients insufficiently responsive to a prostaglandin analogue used alone. Xalacom® is suitable for patients in whom timolol and latanoprost are appropriate choices of beta-blocker and prostaglandin analogue respectively. It costs less than the individual preparations.